Updated Jul 16, 2026
Ragan Paula is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $162K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2024-11-19 | XFOR | X4 Pharmaceuticals, Inc | S — Open-market sale [10b5-1] | 31.9K | $0.39 | $13K |
| 2024-10-16 | XFOR | X4 Pharmaceuticals, Inc | S — Open-market sale [10b5-1] | 31.9K | $0.56 | $18K |
| 2024-10-08 | XFOR | X4 Pharmaceuticals, Inc | S — Open-market sale [10b5-1] | 239.4K | $0.55 | $132K |
| 2024-10-08 | XFOR | X4 Pharmaceuticals, Inc | A — Grant or award [10b5-1] | 532.1K | $0.00 |
Ragan Paula is a corporate insider — currently tracked as President and CEO, Director. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($162K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ragan Paula profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.